Umeclidinium

October 23, 2014November 11, 2015

Combination COPD Therapy Found to Have No Added Benefit

COPD, News

The German Institute for Quality and Efficiency in Health Care (IQWiG) in agreement with the Act on the Reform of the Market for Medicinal Products (AMNOG) examined the benefits of ... Read more

May 30, 2014November 11, 2015

GSK’s Incruse Ellipta Approved By FDA For Treating Chronic Bronchitis, Emphysema, COPD

Chronic Bronchitis, COPD, Emphysema, News

The U.S. Food and Drug Administration (FDA) recently authorized Incruse Ellipta for the treatment of airflow obstruction in patients who suffer from chronic obstructive pulmonary disease (COPD), as well as ... Read more

May 20, 2014November 11, 2015

Anoro COPD Treatment Gets Marketing Authorization in Europe

COPD, News

The European Commission has granted marketing authorization for Anoro (Umeclidinium/Vilanterol), a chronic obstructive pulmonary disease (COPD) treatment, which is currently licensed in Europe as UMEC/VI55mcg/22mcg. GlaxoSmithKline and Theravance announced the now-authorized combination ... Read more